Blue Jet Healthcare Limited (BLUEJET.NS)
INR 744.85
(-0.75%)
INR 744.85
(-0.75%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | 2.41 Billion | 1.41 Billion | 1.43 Billion | 1.29 Billion | 1.22 Billion |
| Net Income | 1.63 Billion | 1.6 Billion | 1.81 Billion | 1.41 Billion | 1.44 Billion |
| Depreciation & Amortization | 280.91 Million | 250.74 Million | 221.46 Million | 196.63 Million | 180.28 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | 131.69 Million | -328.91 Million | -759.63 Million | -727.07 Million | -932.03 Million |
| Other non-cash items | 458.15 Million | 730.72 Million | 1.18 Billion | 1.48 Billion | 530.57 Million |
| Investing Cash Flow | -2.64 Billion | -1.47 Billion | -764.64 Million | -566.48 Million | -452.36 Million |
| Investments in PPE | -1.74 Billion | -592.71 Million | -229.22 Million | -491.5 Million | -160.12 Million |
| Acquisitions | 6.73 Million | 4.11 Million | 14.58 Million | 1.4 Million | - |
| Investment purchases | -1.29 Billion | -1.11 Billion | -550 Million | -101.69 Million | - |
| Sales/Maturities of investments | 393.36 Million | 230.35 Million | - | 25.31 Million | - |
| Other Investing Activities | -908.94 Million | -879.81 Million | -542.41 Million | 53.07 Million | -292.24 Million |
| Financing Cash Flow | -19.86 Million | -42.33 Million | -529.63 Million | -221.9 Million | -724.97 Million |
| Debt repayment | -18.25 Million | -28.8 Million | -525.58 Million | -221.88 Million | -227.4 Million |
| Dividends payments | -20 Thousand | -20 Thousand | -20 Thousand | -20 Thousand | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - |
| Other Financing Activities | -1.59 Million | -13.57 Million | -269 Million | 550 Thousand | -497.57 Million |
| Accounts receivables | 639.53 Million | -96.23 Million | -662.33 Million | -239.22 Million | -1 Billion |
| Accounts payables | -127.32 Million | -33.34 Million | -44.83 Million | 51.81 Million | - |
| Inventory | -41.77 Million | -206.27 Million | 126.85 Million | -486.99 Million | 22.04 Million |
| Other working capital | -338.74 Million | 6.93 Million | -179.32 Million | -52.67 Million | 54.51 Million |
| Cash at beginning of period | 654.38 Million | 753.73 Million | 611.27 Million | 100.72 Million | 50.76 Million |
| Cash at end of period | 847.06 Million | 654.38 Million | 753.73 Million | 611.27 Million | 100.72 Million |
| Capital Expenditure | -1.74 Billion | -592.71 Million | -229.22 Million | -491.5 Million | -160.12 Million |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | 192.68 Million | -99.35 Million | 142.46 Million | 510.55 Million | 49.96 Million |
| Free Cash Flow | 673.91 Million | 822.79 Million | 1.2 Billion | 807.67 Million | 1.06 Billion |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 377.77 Million | 1.63 Billion | 396.54 Million | 321.09 Million | 478.7 Million | 441.21 Million |
| Depreciation & Amortization | - | 280.91 Million | - | - | 64.68 Million | 60.5 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | 131.69 Million | - | - | -9.74 Million | -44.68 Million |
| Other non-cash items | -377.77 Million | 458.15 Million | -396.54 Million | -321.09 Million | -100.65 Million | -24.39 Million |
| Investing Cash Flow | - | -2.64 Billion | - | - | -567.98 Million | -401.33 Million |
| Investments in PPE | - | -1.74 Billion | - | - | -514.9 Million | -301.33 Million |
| Acquisitions | - | 6.73 Million | - | - | - | - |
| Investment purchases | - | -1.29 Billion | - | - | -102.19 Million | -151.2 Million |
| Sales/Maturities of investments | - | 393.36 Million | - | - | 49.12 Million | 51.2 Million |
| Other Investing Activities | - | -908.94 Million | - | - | -53.06 Million | -114.37 Million |
| Financing Cash Flow | - | -19.86 Million | - | - | -4.38 Million | -10 Million |
| Debt repayment | - | -18.25 Million | - | - | -3.97 Million | -9.5 Million |
| Dividends payments | - | -20 Thousand | - | - | - | -20 Thousand |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | -1.59 Million | - | - | -410 Thousand | -480 Thousand |
| Accounts receivables | - | 639.53 Million | - | - | 209.47 Million | 156.48 Million |
| Accounts payables | - | -127.32 Million | - | - | 93.23 Million | 29.46 Million |
| Inventory | - | -41.77 Million | - | - | -146.01 Million | -74.38 Million |
| Other working capital | - | -338.74 Million | - | - | -166.43 Million | -156.24 Million |
| Cash at beginning of period | - | 654.38 Million | - | 554.21 Million | 666.25 Million | 654.38 Million |
| Cash at end of period | - | 847.06 Million | - | 554.21 Million | 717.98 Million | 666.25 Million |
| Capital Expenditure | - | -1.74 Billion | - | - | -514.9 Million | -301.33 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | 192.68 Million | - | - | 51.73 Million | 11.87 Million |
| Free Cash Flow | - | 673.91 Million | - | - | -54.58 Million | 121.87 Million |
000779
AXTELCPO
LOGI-B
688683
XPC
DHC